Submit Deal

BAIN CAPITAL LIFE SCIENCES

HQ - Boston

Summary

Bain Capital Life Sciences is a company investing in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies.

Deals Overview

Total Deals28

Valued Deals28

Total Value£ 6.75 B

Avg. Deal Size£ 241 M

Market Context

Parent Company

BAIN CAPITAL LP

491 transactions

Senior Management

Jonah Cashdan
Vice President
Jeff Schwartz
Managing Director
Matthew Calistri
Managing Director

Sort

23 May 2019|United States|Biotechnology

Target: FREENOME

Bidder: T. ROWE PRICE GROUP INC

17 Service Providers

3 Target | 14 Bidder

30 Dealmakers

8 Target | 24 Bidder

£ 126 M

Value

23 Apr 2020|United States|Biotechnology

Target: AFFINIVAX INC

Bidder: VIKING GLOBAL INVESTORS

7 Service Providers

3 Target | 4 Bidder

16 Dealmakers

9 Target | 7 Bidder

£ 97 M

Value

20 May 2020|United States|Pharmaceuticals

Target: ATEA PHARMACEUTICALS INC

Bidder: ALLY BRIDGE GROUP

15 Service Providers

2 Target | 13 Bidder

27 Dealmakers

4 Target | 24 Bidder

£ 175 M

Value

20 May 2020|United States|Biotechnology

Target: RAPID MICRO BIOSYSTEMS

Bidder: ALLY BRIDGE GROUP

7 Service Providers

3 Target | 4 Bidder

9 Dealmakers

4 Target | 5 Bidder

£ 97 M

Value

16 Jun 2020|United States|Biotechnology

Target: C4 THERAPEUTICS INC

Bidder: RTW INVESTMENTS

16 Service Providers

5 Target | 11 Bidder

26 Dealmakers

3 Target | 22 Bidder

£ 119 M

Value

27 Oct 2020|United States|Health Care Services

Target: THRIVE EARLIER DETECTION CORP

Bidder: EXACT SCIENCES

17 Service Providers

3 Target | 4 Bidder | 10 Vendor

61 Dealmakers

27 Target | 11 Bidder | 23 Vendor

£ 1.65 B

Value

12 Mar 2020|United States|Pharmaceuticals

Target: NURIX THERAPEUTICS

Bidder: BAIN CAPITAL LIFE SCIENCES

7 Service Providers

2 Target | 5 Bidder

10 Dealmakers

4 Target | 6 Bidder

£ 95 M

Value

08 Feb 2021|United States|Biotechnology

Target: NAUTILUS BIOTECHNOLOGY

Bidder: ARYA SCIENCES ACQUISITION CORP III

21 Service Providers

4 Target | 17 Bidder

44 Dealmakers

20 Target | 24 Bidder

£ 654 M

Value

14 Apr 2021|United States|Biotechnology

Target: TANGO THERAPEUTICS

Bidder: CORMORANT ASSET MANAGEMENT

29 Service Providers

5 Target | 24 Bidder

32 Dealmakers

15 Target | 19 Bidder

£ 257 M

Value

24 Feb 2021|United States|Biotechnology

Target: XILIO THERAPEUTICS

Bidder: RIVERVEST VENTURE PARTNERS

3 Service Providers

1 Target | 2 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 64 M

Value

25 Jul 2022|Netherlands|Pharmaceuticals

Target: NEWAMSTERDAM PHARMA HOLDING

Bidder: FRAZIER LIFESCIENCES ACQUISITION CORPOARTION

20 Service Providers

8 Target | 12 Bidder

55 Dealmakers

39 Target | 18 Bidder

£ 270 M

Value

31 Aug 2022|United States|Medical Equipment

Target: JENAVALVE TECHNOLOGY

Bidder: GIMV NV

9 Service Providers

2 Target | 7 Bidder

10 Dealmakers

2 Target | 8 Bidder

£ 85 M

Value